Development of a potency assay for CD34(+) cell-based therapy.

Aries A, Vignon C, Zanetti C, Goubaud A, Cormier A, Diederichs A, Lahlil R, Hénon P, Garitaonandia I

DOI: 10.1038/s41598-023-47079-8
Published: 2023 Nov 11
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-023-47079-8,
  title = {Development of a potency assay for CD34(+) cell-based therapy.},
  author = {Aries A and Vignon C and Zanetti C and Goubaud A and Cormier A and Diederichs A and Lahlil R and Hénon P and Garitaonandia I},
  year = {2023},
  journal = {Scientific reports},
  doi = {10.1038/s41598-023-47079-8},
  url = {https://doi.org/10.1038/s41598-023-47079-8}
}

RIS

TY  - JOUR
TI  - Development of a potency assay for CD34(+) cell-based therapy.
AU  - Aries A
AU  - Vignon C
AU  - Zanetti C
AU  - Goubaud A
AU  - Cormier A
AU  - Diederichs A
AU  - Lahlil R
AU  - Hénon P
AU  - Garitaonandia I
PY  - 2023
JO  - Scientific reports
DO  - 10.1038/s41598-023-47079-8
UR  - https://doi.org/10.1038/s41598-023-47079-8
ER  -

APA

A, A., C, V., C, Z., A, G., A, C., A, D., R, L., P, H., & I, G. (2023). Development of a potency assay for CD34(+) cell-based therapy.. Scientific reports. https://doi.org/10.1038/s41598-023-47079-8

Source records

pubmed · retrieved 2026-09-27T14:05:20.549Z